Closed delwen closed 2 years ago
I'm also thinking of adding the following:
Feel free to add possible questions!
I see this as a living page based on input from the stakeholder interviews.
I went through and made some minor edits for clarity https://github.com/quest-bih/clinical-dashboard/commit/1734ec5f31c95d1b65a38192d002c07ed8134bb4
Agree with adding answers to the questions you highlighted!
I have also made one suggestion. 4f27c30
Regarding the additional questions: I like 1 and 2, I believe 3 is well covered in the current FAQ text.
Also, I felt that the question: "Why did you focus on ClinicalTrials.gov, DRKS, and EUCTR?" was not really answered by the FAQ. What I find missing is a bit of a rationale why IntoValue and the EU Trials Tracker chose their respective samples. (After all, the dashboard just used these data for convenience, right?)
Thanks for your feedback @bgcarlisle and @Martin-R-H! I will incorporate the additional questions (will check again if #3 if really answered already).
"Why did you focus on ClinicalTrials.gov, DRKS, and EUCTR?" → agree. For EUCTR: certain types of trials have to be registered in EudraCT and report results there. CT.gov and DRKS are commonly used registries for trials in Germany, but we would need to show this to really answer this question.
@Martin-R-H I tried to find your edits to the page but couldn't find the commit.
The suggestion I made should now be in the content-update branch b56e4c4
Just pushed the FAQ content. Thanks everyone for your input! 🚀
I updated the FAQ page with some first info. @maia-sh and @bgcarlisle could you review? Thanks!
Changes are pushed to a new branch: https://github.com/quest-bih/clinical-dashboard/blob/content-updates/faq_page.R